ID   CIDEA_HUMAN             Reviewed;         219 AA.
AC   O60543; B0YIY7; Q6UPR7;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   15-MAR-2017, entry version 120.
DE   RecName: Full=Cell death activator CIDE-A;
DE   AltName: Full=Cell death-inducing DFFA-like effector A;
GN   Name=CIDEA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9564035; DOI=10.1093/emboj/17.9.2526;
RA   Inohara N., Koseki T., Chen S., Wu X., Nunez G.;
RT   "CIDE, a novel family of cell death activators with homology to the 45
RT   kDa subunit of the DNA fragmentation factor.";
RL   EMBO J. 17:2526-2533(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PHE-115.
RC   TISSUE=Brain;
RA   Liang L., Xu Z., Li T., Zhao M.;
RT   "Homo sapiens cell death activator CIDE-A mRNA.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   SUBCELLULAR LOCATION, DISEASE, AND TISSUE SPECIFICITY.
RX   PubMed=18509062; DOI=10.1073/pnas.0802063105;
RA   Puri V., Ranjit S., Konda S., Nicoloro S.M., Straubhaar J., Chawla A.,
RA   Chouinard M., Lin C., Burkart A., Corvera S., Perugini R.A.,
RA   Czech M.P.;
RT   "Cidea is associated with lipid droplets and insulin sensitivity in
RT   humans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:7833-7838(2008).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH CIDEC.
RX   PubMed=19843876; DOI=10.1152/ajpendo.00188.2009;
RA   Liu K., Zhou S., Kim J.Y., Tillison K., Majors D., Rearick D.,
RA   Lee J.H., Fernandez-Boyanapalli R.F., Barricklow K., Houston M.S.,
RA   Smas C.M.;
RT   "Functional analysis of FSP27 protein regions for lipid droplet
RT   localization, caspase-dependent apoptosis, and dimerization with
RT   CIDEA.";
RL   Am. J. Physiol. 297:E1395-E1413(2009).
RN   [6]
RP   STRUCTURE BY NMR OF 33-110.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the CIDE-N domain of human cell death activator
RT   CIDE-A.";
RL   Submitted (AUG-2007) to the PDB data bank.
CC   -!- FUNCTION: Acts as a CEBPB coactivator in mammary epithelial cells
CC       to control the expression of a subset of CEBPB downstream target
CC       genes, including ID2, IGF1, PRLR, SOCS1, SOCS3, XDH, but not
CC       casein. By interacting with CEBPB, strengthens the association of
CC       CEBPB with the XDH promoter, increases histone acetylation and
CC       dissociates HDAC1 from the promoter (By similarity). Binds to
CC       lipid droplets and regulates their enlargement, thereby
CC       restricting lipolysis and favoring storage. At focal contact sites
CC       between lipid droplets, promotes directional net neutral lipid
CC       transfer from the smaller to larger lipid droplets. The transfer
CC       direction may be driven by the internal pressure difference
CC       between the contacting lipid droplet pair and occurs at a lower
CC       rate than that promoted by CIDEC. When overexpressed, induces
CC       apoptosis. The physiological significance of its role in apoptosis
CC       is unclear. {ECO:0000250, ECO:0000269|PubMed:19843876}.
CC   -!- SUBUNIT: Directly interacts with CEBPB (By similarity). Interacts
CC       with CIDEC. {ECO:0000250, ECO:0000269|PubMed:19843876}.
CC   -!- SUBCELLULAR LOCATION: Lipid droplet {ECO:0000269|PubMed:18509062}.
CC       Nucleus {ECO:0000250}. Note=Enriched at lipid droplet contact
CC       sites. Has been shown to localize to mitonchondria, where it could
CC       interact with UCP1 and hence inhibit UCP1 uncoupling activity (By
CC       similarity). These data could not be confirmed (PubMed:18509062).
CC       {ECO:0000250, ECO:0000269|PubMed:18509062}.
CC   -!- TISSUE SPECIFICITY: Expressed in omental and subcutaneous adipose
CC       tissue (at protein level). {ECO:0000269|PubMed:18509062}.
CC   -!- DISEASE: Note=In omental and subcutaneous adipose tissue of obese
CC       patients matched for BMI, expression levels correlate with insulin
CC       sensitivity. Expression is increased 5-6 fold in the group of
CC       patients with high insulin sensitivity, compared to the insulin-
CC       resistant group. This observation is consistent with the idea that
CC       triglyceride storage in adipocytes plays an important role in
CC       sequestering triglycerides and fatty acids away from the
CC       circulation and peripheral tissues, thus enhancing insulin
CC       sensitivity in liver and muscle. {ECO:0000269|PubMed:18509062}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF041378; AAC34987.1; -; mRNA.
DR   EMBL; AY364639; AAQ65241.1; -; mRNA.
DR   EMBL; EF444967; ACA05966.1; -; Genomic_DNA.
DR   CCDS; CCDS11856.1; -.
DR   RefSeq; NP_001270.1; NM_001279.3.
DR   UniGene; Hs.249129; -.
DR   PDB; 2EEL; NMR; -; A=33-110.
DR   PDBsum; 2EEL; -.
DR   ProteinModelPortal; O60543; -.
DR   SMR; O60543; -.
DR   BioGrid; 107570; 11.
DR   IntAct; O60543; 3.
DR   MINT; MINT-7002607; -.
DR   STRING; 9606.ENSP00000320209; -.
DR   iPTMnet; O60543; -.
DR   BioMuta; CIDEA; -.
DR   PaxDb; O60543; -.
DR   PeptideAtlas; O60543; -.
DR   PRIDE; O60543; -.
DR   Ensembl; ENST00000320477; ENSP00000320209; ENSG00000176194.
DR   GeneID; 1149; -.
DR   KEGG; hsa:1149; -.
DR   UCSC; uc002kqt.5; human.
DR   CTD; 1149; -.
DR   DisGeNET; 1149; -.
DR   GeneCards; CIDEA; -.
DR   HGNC; HGNC:1976; CIDEA.
DR   MIM; 604440; gene.
DR   neXtProt; NX_O60543; -.
DR   OpenTargets; ENSG00000176194; -.
DR   PharmGKB; PA26514; -.
DR   eggNOG; ENOG410IVIC; Eukaryota.
DR   eggNOG; ENOG4111SUV; LUCA.
DR   GeneTree; ENSGT00390000018596; -.
DR   HOGENOM; HOG000029211; -.
DR   HOVERGEN; HBG050961; -.
DR   InParanoid; O60543; -.
DR   OMA; AQITGQF; -.
DR   OrthoDB; EOG091G0H6W; -.
DR   PhylomeDB; O60543; -.
DR   TreeFam; TF334321; -.
DR   Reactome; R-HSA-73923; Lipid digestion, mobilization, and transport.
DR   EvolutionaryTrace; O60543; -.
DR   GeneWiki; CIDEA; -.
DR   GenomeRNAi; 1149; -.
DR   PRO; PR:O60543; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000176194; -.
DR   CleanEx; HS_CIDEA; -.
DR   ExpressionAtlas; O60543; baseline and differential.
DR   Genevisible; O60543; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005811; C:lipid particle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005740; C:mitochondrial envelope; ISS:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; ISS:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; ISS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0008219; P:cell death; ISS:BHF-UCL.
DR   GO; GO:0006629; P:lipid metabolic process; ISS:BHF-UCL.
DR   GO; GO:0019915; P:lipid storage; ISS:BHF-UCL.
DR   GO; GO:0050710; P:negative regulation of cytokine secretion; IMP:BHF-UCL.
DR   GO; GO:1900118; P:negative regulation of execution phase of apoptosis; ISS:BHF-UCL.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; IMP:BHF-UCL.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:BHF-UCL.
DR   GO; GO:0010890; P:positive regulation of sequestering of triglyceride; ISS:BHF-UCL.
DR   GO; GO:1902510; P:regulation of apoptotic DNA fragmentation; ISS:BHF-UCL.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0035634; P:response to stilbenoid; IEA:Ensembl.
DR   GO; GO:0001659; P:temperature homeostasis; ISS:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR032936; CIDE-A.
DR   InterPro; IPR003508; CIDE-N_dom.
DR   PANTHER; PTHR12306:SF21; PTHR12306:SF21; 1.
DR   Pfam; PF02017; CIDE-N; 1.
DR   SMART; SM00266; CAD; 1.
DR   PROSITE; PS51135; CIDE_N; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Apoptosis; Complete proteome; Lipid droplet;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    219       Cell death activator CIDE-A.
FT                                /FTId=PRO_0000144718.
FT   DOMAIN       33    110       CIDE-N. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00447}.
FT   VARIANT     115    115       V -> F (in dbSNP:rs11545881).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_048738.
FT   STRAND       35     40       {ECO:0000244|PDB:2EEL}.
FT   STRAND       48     54       {ECO:0000244|PDB:2EEL}.
FT   HELIX        55     65       {ECO:0000244|PDB:2EEL}.
FT   STRAND       69     71       {ECO:0000244|PDB:2EEL}.
FT   STRAND       73     77       {ECO:0000244|PDB:2EEL}.
FT   TURN         78     80       {ECO:0000244|PDB:2EEL}.
FT   HELIX        87     90       {ECO:0000244|PDB:2EEL}.
FT   STRAND       95    103       {ECO:0000244|PDB:2EEL}.
SQ   SEQUENCE   219 AA;  24687 MW;  05F704823CE71C0E CRC64;
     MEAARDYAGA LIRPLTFMGS QTKRVLFTPL MHPARPFRVS NHDRSSRRGV MASSLQELIS
     KTLDALVIAT GLVTLVLEED GTVVDTEEFF QTLGDNTHFM ILEKGQKWMP GSQHVPTCSP
     PKRSGIARVT FDLYRLNPKD FIGCLNVKAT MYEMYSVSYD IRCTGLKGLL RSLLRFLSYS
     AQVTGQFLIY LGTYMLRVLD DKEERPSLRS QAKGRFTCG
//
